Computational modeling of lung deposition of inhaled particles in chronic obstructive pulmonary disease (COPD) patients: identification of gaps in knowledge and data

  • Koustav Ganguly
    Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden;
  • Ulrika Carlander
    Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden;
  • Estella DG Garessus
    Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden;
  • Markus Fridén
    Respiratory, Inflammation and Autoimmunity IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden;
  • Ulf G Eriksson
    Early Clinical Development, IMED Biotech Unit, Quantitative Clinical Pharmacology, AstraZeneca, Gothenburg, Sweden;
  • Ulrika Tehler
    Pharmaceutical Sciences, IMED Biotech Unit, Early Product Development, AstraZeneca, Gothenburg, Sweden
  • Gunnar Johanson
    Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden;

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ